People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Panacela Labs, Inc. | — | Biotechnology | Series B | $39.9M | $115.2M | 2011 |
Dmitry Lisenkov at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dmitry Lisenkov on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Leah Brownlee | 1 | 4 |
| Michael Fonstein | 1 | 3 |
| Andrei Gudkov | 1 | 2 |
| Leysan Shaydullina | 1 | 1 |
| Yakov Lyons Kogan | 1 | 1 |
| Andrei Lyons Gudkov | 1 | 1 |
| Dmitry Tyomkin | 1 | 1 |
| Oleg Kiselev | 1 | 1 |
| Neil Lyons C | 1 | 1 |
| Dmitry Lyons Lisenkov | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.